The pathophysiology of the development of migraine from estrogen in women of childbearing age: review
Main Author: | |
---|---|
Publication Date: | 2024 |
Other Authors: | , , , , , |
Format: | Article |
Language: | eng |
Source: | Revista Headache Medicine (Online) |
Download full: | https://headachemedicine.com.br/index.php/hm/article/view/1221 |
Summary: | TÍTULO: “The pathophysiology of the development of migraine from estrogen in women of childbearing age: review” INTRODUÇÃO: Changes in estrogen levels can trigger headaches, including estrogen-associated migraine. These changes can occur naturally (e.g., menstruation, pregnancy, menopause) or can be induced (e.g., hormonal contraceptives, hormone replacement therapy, anti-estrogen agents). OBJETIVO: The aim of this review is to investigate the pathophysiology of the development of migraine from estrogen in women of childbearing age. MÉTODO: This Integrative Literature Review was developed based on the steps described by Marcela Tavares de Souza, Michelly Dias da Silva and Rachel de Carvalho (Albert Einstein Israelita Hospital), in the article: “Integrative review: what is it? How to do it?”. To assess and analyze literature data we searched for the following terms: (Estrogen ) AND ("Migraine Disorders ") AND (Physiopathology) (MESH or text words) in PubMed and Medline (acess through the Biblioteca Virtual em Saúde), and yielded 19 relevant studies. We included original articles and reviews, in full, which respond to the objective of the study and which are in Portuguese or in English. We excluded research that did not reach the objective, articles that did not cover the theme or animal or in vitro testing. RESULTADO: The studies consistently reveal a significant association between abrupt estrogen ‘‘withdrawal’’ during the late luteal phase and the pathophysiology of menstrual migraine. The drop in estrogen levels may have a pro-nociceptive effect as its main route, facilitating cortical responses to painful stimuli, through its association with ERK, modulation of the trigeminovascular system and the serotonergic, opioid, noradrenergic, glutamatergic and GABAergic neurotransmitter systems . Studies also indicate that the increase in prostaglandin levels and the vasodilatory effect mediated by estrogen withdrawal are important factors in the pathophysiology of migraine. Other studies suggest an association between mineral homeostasis and oxidative stress with the incidence of headaches mediated by female sex hormones. One study suggested that high plasma concentrations of estrogen appear to be associated with migraine attacks with aura. The action of progesterone still has ambiguous results. CONCLUSÃO: The action of estrogen on the pathophysiology of migration occurs through many distinct pathways. Understanding these means is necessary to develop efficient treatments that increase patients' quality of life. |
id |
SBC_409e9b82045fc56e70d43f86af21f5eb |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/1221 |
network_acronym_str |
SBC |
network_name_str |
Revista Headache Medicine (Online) |
repository_id_str |
|
spelling |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: reviewEstrogenMigraine DisorderPathophysiologyTÍTULO: “The pathophysiology of the development of migraine from estrogen in women of childbearing age: review” INTRODUÇÃO: Changes in estrogen levels can trigger headaches, including estrogen-associated migraine. These changes can occur naturally (e.g., menstruation, pregnancy, menopause) or can be induced (e.g., hormonal contraceptives, hormone replacement therapy, anti-estrogen agents). OBJETIVO: The aim of this review is to investigate the pathophysiology of the development of migraine from estrogen in women of childbearing age. MÉTODO: This Integrative Literature Review was developed based on the steps described by Marcela Tavares de Souza, Michelly Dias da Silva and Rachel de Carvalho (Albert Einstein Israelita Hospital), in the article: “Integrative review: what is it? How to do it?”. To assess and analyze literature data we searched for the following terms: (Estrogen ) AND ("Migraine Disorders ") AND (Physiopathology) (MESH or text words) in PubMed and Medline (acess through the Biblioteca Virtual em Saúde), and yielded 19 relevant studies. We included original articles and reviews, in full, which respond to the objective of the study and which are in Portuguese or in English. We excluded research that did not reach the objective, articles that did not cover the theme or animal or in vitro testing. RESULTADO: The studies consistently reveal a significant association between abrupt estrogen ‘‘withdrawal’’ during the late luteal phase and the pathophysiology of menstrual migraine. The drop in estrogen levels may have a pro-nociceptive effect as its main route, facilitating cortical responses to painful stimuli, through its association with ERK, modulation of the trigeminovascular system and the serotonergic, opioid, noradrenergic, glutamatergic and GABAergic neurotransmitter systems . Studies also indicate that the increase in prostaglandin levels and the vasodilatory effect mediated by estrogen withdrawal are important factors in the pathophysiology of migraine. Other studies suggest an association between mineral homeostasis and oxidative stress with the incidence of headaches mediated by female sex hormones. One study suggested that high plasma concentrations of estrogen appear to be associated with migraine attacks with aura. The action of progesterone still has ambiguous results. CONCLUSÃO: The action of estrogen on the pathophysiology of migration occurs through many distinct pathways. Understanding these means is necessary to develop efficient treatments that increase patients' quality of life.TÍTULO: “A fisiopatologia do desenvolvimento de migrânea pelo estrogênio em mulheres em idade fértil: revisão” INTRODUÇÃO: Alterações nos níveis de estrogênio podem desencadear dores de cabeça, incluindo migrânea associada ao estrogênio. Estas alterações podem ocorrer naturalmente (por exemplo, pela menstruação, gravidez, menopausa) ou podem ser induzidas (por exemplo, por contraceptivos hormonais, terapia de reposição hormonal, agentes antiestrogênio). OBJETIVO: O objetivo desta revisão é investigar a fisiopatologia do desenvolvimento da migrânea por estrogênio em mulheres em idade fértil. MÉTODO: Esta Revisão Integrativa da Literatura foi desenvolvida com base nas etapas descritas por Marcela Tavares de Souza, Michelly Dias da Silva e Rachel de Carvalho (Hospital Albert Einstein Israelita), no artigo: “Revisão integrativa: o que é? Como fazer isso?". Para avaliação e análise dos dados da literatura buscamos os seguintes termos: (Estrogen ) AND ("Migraine Disorders") AND (Physiopathology) (MESH ou palavras de texto) no PubMed e Medline (acesso pela Biblioteca Virtual em Saúde), e obtivemos 19 estudos relevantes. Foram incluídos artigos originais e revisões, na íntegra, que respondam ao objetivo do estudo e que estejam em português ou em inglês. Foram excluídas pesquisas que não atingiram o objetivo, artigos que não abordavam o tema ou testes em animais ou in vitro. RESULTADO: Os estudos revelam consistentemente uma associação significativa entre a “retirada” abrupta de estrogênio durante a fase lútea tardia e a fisiopatologia da enxaqueca menstrual. A queda dos níveis de estrogênio pode ter como principal via efeito pró-nociceptivo, facilitando respostas corticais a estímulos dolorosos, através de sua associação com ERK, modulação do sistema trigeminovascular e dos sistemas neurotransmissores serotoninérgico, opióide, noradrenérgico, glutamatérgico e GABAérgico. Estudos também indicam que o aumento dos níveis de prostaglandinas e o efeito vasodilatador mediado pela retirada do estrogênio são fatores importantes na fisiopatologia da migrânea. Outros estudos sugerem associação entre homeostase mineral e estresse oxidativo com a incidência de dores de cabeça mediadas por hormônios sexuais femininos. Um estudo sugeriu que altas concentrações plasmáticas de estrogênio parecem estar associadas a crises de enxaqueca com aura. A ação da progesterona ainda apresenta resultados ambíguos. CONCLUSÃO: A ação do estrogênio na fisiopatologia da migração ocorre por diversas vias distintas. A compreensão desses meios é necessária para desenvolver tratamentos eficientes que aumentem a qualidade de vida dos pacientes.Sociedade Brasileira de Cefaleia2024-08-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://headachemedicine.com.br/index.php/hm/article/view/1221Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 91Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 912763-6178reponame:Revista Headache Medicine (Online)instname:Sociedade Brasileira de Cefaleiainstacron:SBCenghttps://headachemedicine.com.br/index.php/hm/article/view/1221/1857Copyright (c) 2024 VALENTINA GASPARIM, Carolina Langaro Brockmann, Giovanna Lourenço Cavagnoli, Lara Sabrinna Noronha Lima, Luís Fernando Rafalski Pereira, Thaís Barbosa Mourão Gomes, Patricia Leen Kosako Cerutti (Author)https://creativecommons.org/licenses/by/4.0/deed.ptinfo:eu-repo/semantics/openAccessGASPARIM, VALENTINABrockmann, Carolina LangaroCavagnoli, Giovanna LourençoLima, Lara Sabrinna NoronhaPereira, Luís Fernando RafalskiGomes, Thaís Barbosa MourãoCerutti, Patricia Leen Kosako2024-10-01T01:01:09Zoai:ojs.pkp.sfu.ca:article/1221Revistahttp://headachemedicine.com.brPRIhttps://headachemedicine.com.br/index.php/hm/oaimmvalenca@yahoo.com.br | support@headachemedicine.com.br2763-61782178-7468opendoar:2024-10-01T01:01:09Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleiafalse |
dc.title.none.fl_str_mv |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
title |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
spellingShingle |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review GASPARIM, VALENTINA Estrogen Migraine Disorder Pathophysiology |
title_short |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
title_full |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
title_fullStr |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
title_full_unstemmed |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
title_sort |
The pathophysiology of the development of migraine from estrogen in women of childbearing age: review |
author |
GASPARIM, VALENTINA |
author_facet |
GASPARIM, VALENTINA Brockmann, Carolina Langaro Cavagnoli, Giovanna Lourenço Lima, Lara Sabrinna Noronha Pereira, Luís Fernando Rafalski Gomes, Thaís Barbosa Mourão Cerutti, Patricia Leen Kosako |
author_role |
author |
author2 |
Brockmann, Carolina Langaro Cavagnoli, Giovanna Lourenço Lima, Lara Sabrinna Noronha Pereira, Luís Fernando Rafalski Gomes, Thaís Barbosa Mourão Cerutti, Patricia Leen Kosako |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
GASPARIM, VALENTINA Brockmann, Carolina Langaro Cavagnoli, Giovanna Lourenço Lima, Lara Sabrinna Noronha Pereira, Luís Fernando Rafalski Gomes, Thaís Barbosa Mourão Cerutti, Patricia Leen Kosako |
dc.subject.por.fl_str_mv |
Estrogen Migraine Disorder Pathophysiology |
topic |
Estrogen Migraine Disorder Pathophysiology |
description |
TÍTULO: “The pathophysiology of the development of migraine from estrogen in women of childbearing age: review” INTRODUÇÃO: Changes in estrogen levels can trigger headaches, including estrogen-associated migraine. These changes can occur naturally (e.g., menstruation, pregnancy, menopause) or can be induced (e.g., hormonal contraceptives, hormone replacement therapy, anti-estrogen agents). OBJETIVO: The aim of this review is to investigate the pathophysiology of the development of migraine from estrogen in women of childbearing age. MÉTODO: This Integrative Literature Review was developed based on the steps described by Marcela Tavares de Souza, Michelly Dias da Silva and Rachel de Carvalho (Albert Einstein Israelita Hospital), in the article: “Integrative review: what is it? How to do it?”. To assess and analyze literature data we searched for the following terms: (Estrogen ) AND ("Migraine Disorders ") AND (Physiopathology) (MESH or text words) in PubMed and Medline (acess through the Biblioteca Virtual em Saúde), and yielded 19 relevant studies. We included original articles and reviews, in full, which respond to the objective of the study and which are in Portuguese or in English. We excluded research that did not reach the objective, articles that did not cover the theme or animal or in vitro testing. RESULTADO: The studies consistently reveal a significant association between abrupt estrogen ‘‘withdrawal’’ during the late luteal phase and the pathophysiology of menstrual migraine. The drop in estrogen levels may have a pro-nociceptive effect as its main route, facilitating cortical responses to painful stimuli, through its association with ERK, modulation of the trigeminovascular system and the serotonergic, opioid, noradrenergic, glutamatergic and GABAergic neurotransmitter systems . Studies also indicate that the increase in prostaglandin levels and the vasodilatory effect mediated by estrogen withdrawal are important factors in the pathophysiology of migraine. Other studies suggest an association between mineral homeostasis and oxidative stress with the incidence of headaches mediated by female sex hormones. One study suggested that high plasma concentrations of estrogen appear to be associated with migraine attacks with aura. The action of progesterone still has ambiguous results. CONCLUSÃO: The action of estrogen on the pathophysiology of migration occurs through many distinct pathways. Understanding these means is necessary to develop efficient treatments that increase patients' quality of life. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-08-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/1221 |
url |
https://headachemedicine.com.br/index.php/hm/article/view/1221 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/1221/1857 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/deed.pt info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/deed.pt |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
dc.source.none.fl_str_mv |
Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 91 Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 91 2763-6178 reponame:Revista Headache Medicine (Online) instname:Sociedade Brasileira de Cefaleia instacron:SBC |
instname_str |
Sociedade Brasileira de Cefaleia |
instacron_str |
SBC |
institution |
SBC |
reponame_str |
Revista Headache Medicine (Online) |
collection |
Revista Headache Medicine (Online) |
repository.name.fl_str_mv |
Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleia |
repository.mail.fl_str_mv |
mmvalenca@yahoo.com.br | support@headachemedicine.com.br |
_version_ |
1838629562548748288 |